What impact has the pulmonary embolism pathway had?
Evaluation of the new outpatient pulmonary embolism pathway showed that about 30% of patients could be managed safely and effectively via this route. Kieron Power, Principal Pharmacist for […]
Evaluation of the new outpatient pulmonary embolism pathway showed that about 30% of patients could be managed safely and effectively via this route. Kieron Power, Principal Pharmacist for […]
The pulmonary embolism pathway has been designed to ensure acute risk assessment and appropriate follow up for all pulmonary embolism patients whether treated as inpatients or outpatients, according […]
Improved diagnostic techniques mean that many more low-risk pulmonary embolisms are being diagnosed now. However, a recent national report identified numerous shortcomings in the management of pulmonary embolism […]
Kieron Power is Principal Pharmacist for Thrombosis and Anticoagulation in Swansea Bay University Health Board in South Wales. He has played a leading role in the development of […]
The European Medicines Agency (EMA) has recommended ten new products for approval at a bumper June meeting which also saw therapeutic extensions granted for eleven drugs. The watchdog’s […]
As part of a campaign to reduce the harms caused by cigarette smoking and vaping the Australian Government has introduced restrictions on the ways in which vapes can […]
Results from a national survey indicate that many Americans, 61%, are unaware that primary care physicians can prescribe medications for opioid use disorder, and 13% incorrectly believed that they could […]
A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new […]
Few people in the UK with early stage Alzheimer’s disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet […]
Steve Tomlin is a pharmacist and Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London. His mission is […]
Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that […]
As Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London, Steve Tomlin now uses his experience of hands-on […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
